Oz, as would recall Gray and sirtex ere a case study on many levels, not least his win against the Uni of WA, that turned uni contracts with their professors inside out.
And then the stake owned by the cancer research council in WA, that Bruce controlled and sank the original bid for SRX back in the early 2000s. He voted his shares for the deal and cancer shares against. Go figure.
Would probably make a great PHD study.
Ann: First patient treated in the UK for the TRIPP-FXX study, page-20
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $3.293K | 720.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 23973265 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 9017803 | 9 |
View Market Depth
| Last trade - 13.28pm 27/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |